Esperite N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
14 mei 2014 - 08:07
Statutaire naam
Esperite N.V.
Titel
Cryo-Save Group N.V. - Cryo-Save Group N.V. announces strategy and the acquisition of Salveo Biotechnology's Swiss laboratory and related activities.
Bericht
Cryo-Save - New management announces strategy to enter fields of predictive medicine and translational regenerative medicine R&D, the change of the holding company's name to Esperite, the reorganization of its operations into three separate business units - cord blood and tissue cryo-preservation, proteomics and genomics predictive medicine, and translational regenerative medicine R&D - and the related acquisition of Salveo Biotechnology's Swiss laboratory and related activities.
Gerelateerde downloads
Datum laatste update: 27 december 2025